Expert presentation

>15 minutes

2022: EoE Year in Review

Topic: Burden Of Disease Pathophysiology

Tags: Pathophysiology  Eosinophilic Esophagitis  Expert opinion 

2022: EoE Year in Review

Join Dr. Ikuo Hirano for this informative review of highlights from key scientific advances in eosinophilic esophagitis.

 

 

 

 

Full video

Play full video

 

Join Dr. Ikuo Hirano for this informative review of highlights from key scientific advances in eosinophilic esophagitis

 

 

 

 

 

 

 

Introduction

Welcome

 

Dr. Ikuo Hirano introduces this review of scientific advances in eosinophilic esophagitis

 

 

 

 

 

 

Evolving Approaches to Diagnosis and Monitoring

Endoscopic Approach to Eosinophilic Esophagitis: American Society for Gastrointestinal Endoscopy Consensus Conference

 

Review of Endoscopic Approach to Eosinophilic Esophagitis: American Society for Gastrointestinal Endoscopy Consensus Conference

 

 

 

 

 

 

Monitoring Patients With Eosinophilic Esophagitis in Routine Clinical Practice – International Expert Recommendations

 

Review of Monitoring Patients With Eosinophilic Esophagitis in Routine Clinical Practice – International Expert Recommendations

 

 

 

 

 

 

A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions

 

Review of A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions

 

 

 

 

 

 

Reliability and Responsiveness of Endoscopic Disease Activity Assessment in Eosinophilic Esophagitis

 

Review of Reliability and Responsiveness of Endoscopic Disease Activity Assessment in Eosinophilic Esophagitis

 

 

 

 

 

 

Real-World Evidence in EoE

Poor Adherence to Medical and Dietary Treatments in Adult Patients With Eosinophilic Esophagitis

 

Review of Poor Adherence to Medical and Dietary Treatments in Adult Patients With Eosinophilic Esophagitis

 

 

 

 

 

 

A Real-World Study of Cumulative Steroid Burden in Patients With Newly Diagnosed Eosinophilic Esophagitis

 

Review of A Real-World Study of Cumulative Steroid Burden in Patients With Newly Diagnosed Eosinophilic Esophagitis

 

 

 

 

 

 

Summary

Closing Remarks

 

Dr. Ikuo Hirano provides his closing remarks

 

 

 

MAT-US-2304224 v1.0 - P Expiration Date: 06/02/2025

Welcome to the ADVENT program website

ADVENT is a medical education program by Sanofi and Regeneron. This website is intended only for health care professionals in the US only.

I AM A HEALTHCARE PROVIDER
I AM NOT A HEALTHCARE PROVIDER

ADVENT is a global medical education program by Sanofi and Regeneron and is only intended for healthcare providers.

You are leaving the ADVENT program website

Sanofi Genzyme does not review or control the content of non–Sanofi Genzyme websites, and this hyperlink does not constitute an endorsement by Sanofi Genzyme of the site’s content. Sanofi Genzyme’s privacy procedures do not apply to the owners of a non–Sanofi Genzyme website.

LEAVE THIS SITE GO BACK TO ADVENT PROGRAM